deferoxamine and ponatinib

deferoxamine has been researched along with ponatinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ali Sheikh, MS; Luo, XJ; Peng, J; Tang, LJ; Tu, H; Xiong, XM; Yuan, C; Zhang, JJ; Zhang, XJ; Zhou, YJ	1

Other Studies

1 other study(ies) available for deferoxamine and ponatinib

Article	Year
Combination of ponatinib with deferoxamine synergistically mitigates ischemic heart injury via simultaneous prevention of necroptosis and ferroptosis. European journal of pharmacology, 2021, May-05, Volume: 898 Topics: Animals; Cell Line; Deferoxamine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ferroptosis; Imidazoles; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necroptosis; Pyridazines; Rats, Sprague-Dawley; Signal Transduction	2021

Article

Year

Combination of ponatinib with deferoxamine synergistically mitigates ischemic heart injury via simultaneous prevention of necroptosis and ferroptosis.

European journal of pharmacology, 2021, May-05, Volume: 898

Topics: Animals; Cell Line; Deferoxamine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ferroptosis; Imidazoles; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necroptosis; Pyridazines; Rats, Sprague-Dawley; Signal Transduction

2021